DIATRIZOATE MEGLUMINE AND DIATRI. Key specifications include administration: ORAL, special_features: BT W/GRADUATED SCALE AT 10 ML INTERVALS, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 20, primary_container_content_quantity: 100.000 MILLILITERS. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System under NSN 6505-01-180-6946, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | BT W/GRADUATED SCALE AT 10 ML INTERVALS |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 20 |
| primary_container_content_quantity | 100.000 MILLILITERS |
| active_medicament_medicinal_strength | 66.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT |
| NSN | 6505-01-180-6946 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 20 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 66.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT |
| SPECIAL FEATURES | BT W/GRADUATED SCALE AT 10 ML INTERVALS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER TYPE | BOTTLE |